Christopher Gibson

Current title:
PhD Candidate
Masters of Science in Engineering Physics, Queen’s University, Canada

  • Faculty of Medicine, Department of Medical Biophysics, University of Toronto
  • Princess Margaret Cancer Institute, University Health Network

Christopher Gibson graduated from Engineering Physics at Queen’s University (Kingston, Canada), with a specialty in Electrical Engineering. He is currently studying Medical Biophysics at the University of Toronto and joined our lab in 2017 to pursue his postdoctoral degree.

23% of Canadian patients who undergo breast conserving surgery for early stage breast cancer require reoperation within 1 year to remove residual tumour cells not detected in the initial surgery. My research involves the development of a new handheld fluorescence imaging camera that can be used during breast cancer surgeries to detect tumour cells at the margins, both inside the surgical cavity and on excised specimens. This device is to be used intraoperatively in combination with the prodrug 5-aminolevulinic acid (5-ALA) for fluorescence-guided resection of breast tumours with the goal of enhancing surgeons’ abilities to visualize breast tumors.